These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
122 related articles for article (PubMed ID: 4205659)
21. Current concepts on myocardial depressant factor. Giuseppe T; Marco S; Sigfrido I; Pasquale M; Giorgio C Mater Med Pol; 1989; 21(1):53-6. PubMed ID: 2699345 [TBL] [Abstract][Full Text] [Related]
22. Cardiodepressant and cardiostimulant factors in shock. Nagy S Prog Clin Biol Res; 1987; 236A():599-610. PubMed ID: 3615454 [No Abstract] [Full Text] [Related]
23. [Effect of proteinase inhibition on leukocytal phagocytosis in shock]. Burkhardt K; Bodewig C; Crone-Münzenbrook K Med Welt; 1976 May; 27(19):929-31. PubMed ID: 1083931 [No Abstract] [Full Text] [Related]
24. [Current status of the myocardial depressant factor (MDF) and shock]. Favaro R; Pelaia P Minerva Anestesiol; 1979; 45(7-8):594-600. PubMed ID: 548819 [No Abstract] [Full Text] [Related]
25. Reticuloendothelial system and neuro-endocrine stimulation in shock therapy. Altura BM Adv Shock Res; 1980; 3():3-25. PubMed ID: 7030014 [No Abstract] [Full Text] [Related]
26. Myocardial depressant factor. A peptide: its significance in cardiogenic shock. Okuda M; Fukui T Jpn Circ J; 1974 Jun; 38(6):497-508. PubMed ID: 4436943 [No Abstract] [Full Text] [Related]
27. Inhibition of proteinase in shock treatment. Schnells G Acta Anaesthesiol Belg; 1974; 25(1):143-66. PubMed ID: 4546243 [No Abstract] [Full Text] [Related]
28. A study of the myocardial depressant factor and its relative influence in drug/alcohol mortality. Manning TJ; Williams LE; Lynch VD; Bidanset JH; Drake W; Lukash L J Forensic Sci; 1980 Jul; 25(3):550-63. PubMed ID: 7400768 [TBL] [Abstract][Full Text] [Related]
29. [Shock and MDF]. Shimizu R Kokyu To Junkan; 1972 May; 20(5):433-41. PubMed ID: 4574841 [No Abstract] [Full Text] [Related]
30. Bradykinin in human shock. Attar SM; Tingey HB; McLaughlin JS; Cowley RA Surg Forum; 1967; 18():46-7. PubMed ID: 5300149 [No Abstract] [Full Text] [Related]
31. [Comparative assessment of the therapeutic effect of inhitryl in tourniquet shock (experimental study)]. Kharchenko VZ; Protsenko VA; Usharovich SM Farmakol Toksikol; 1977; 40(2):187-90. PubMed ID: 300691 [No Abstract] [Full Text] [Related]
32. The role of lysosomes in lymphocyte transformation in vitro. Tchórzewski H Arch Immunol Ther Exp (Warsz); 1972; 20(6):831-5. PubMed ID: 4541463 [No Abstract] [Full Text] [Related]
33. Lysosomal functions in circulatory shock. Alho A Ann Chir Gynaecol Fenn; 1971; 60(4):159-64. PubMed ID: 4945489 [No Abstract] [Full Text] [Related]
34. MDF: its participation in the pathophysiology of shock. Okada K; Kosugi I; Tanokura Y; Tajimi K; Ohmura A; Innami H; Tsukamoto T; Inaba T Prog Clin Biol Res; 1983; 111():125-46. PubMed ID: 6867021 [No Abstract] [Full Text] [Related]
35. Detection by chemical methods of a myocardial depressant factor in plasma of animals in circulatory shock. Barenholz Y; Leffler JN; Lefer AM Isr J Med Sci; 1973 May; 9(5):640-7. PubMed ID: 4717947 [No Abstract] [Full Text] [Related]
36. Actions of opiate antagonists with selective receptor interactions in hemorrhagic shock. Curtis MT; Lefer AM Circ Shock; 1983; 10(2):131-45. PubMed ID: 6301706 [TBL] [Abstract][Full Text] [Related]
37. [Physiological effect of myocardial depressant factor (author's transl)]. Kosugi I; Yamaguchi Y; Okada K Kokyu To Junkan; 1975 Sep; 23(9):805-10. PubMed ID: 1239066 [No Abstract] [Full Text] [Related]
38. Proteolysis in formation of a myocardial depressant factor during shock. Leffler JN; Litvin Y; Barenholz Y; Lefer AM Am J Physiol; 1973 Apr; 224(4):824-31. PubMed ID: 4698799 [No Abstract] [Full Text] [Related]